Genell L. Knatterud

20.2k citations

106 papers · 10.6k indexed · 4 hit papers · h-index 40

Cardiology and Cardiovascular Medicine top 0.2%
Surgery top 0.5%
Radiology, Nuclear Medicine and Imaging top 0.5%
Pulmonary and Respiratory Medicine top 1%
Epidemiology top 2%

Co-authors: Michael L. Terrin Jeffrey Borer James E. Dalen Sandra Forman Robert Roberts Lawrence S. Cohen James H. Chesebro Charles K. Francis
Topics: Acute Myocardial Infarction Research (34 papers)Coronary Interventions and Diagnostics (26 papers)Cardiac Imaging and Diagnostics (24 papers)
Cited by: Cardiology and Cardiovascular Medicine Internal Medicine Radiology, Nuclear Medicine and Imaging
Journals: New England Journal of Medicine JAMA Circulation
Partner nations: United States Canada Poland

In The Last Decade

Genell L. Knatterud

106 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1987 1.8k citations Genell L. Knatterud et al. profile →
Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis

2001 1.2k citations Robert P. Baughman, Alvin S. Teirstein et al. American Journal of Respiratory and Critical Care Medicine profile →
Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin

1991 1.1k citations Genell L. Knatterud et al. profile →
Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1988 792 citations Anupama Rao, Craig M. Pratt et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Genell L. Knatterud

Since Specialization

Citations

This map shows the geographic impact of Genell L. Knatterud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genell L. Knatterud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genell L. Knatterud more than expected).

Fields of papers citing papers by Genell L. Knatterud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Genell L. Knatterud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genell L. Knatterud. The network helps show where Genell L. Knatterud may publish in the future.

Co-authorship network of co-authors of Genell L. Knatterud

This figure shows the co-authorship network connecting the top 25 collaborators of Genell L. Knatterud. A scholar is included among the top collaborators of Genell L. Knatterud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Genell L. Knatterud. Genell L. Knatterud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sarcoidosis: social predictors of severity at presentation 2004 ·European Respiratory Journal ·David L. Rabin,Bruce Thompson,Kevin M. Brown,Marc A. Judson,Xuelin Huang,Daniel T. Lackland,Genell L. Knatterud,Henry Yeager,Cecile S. Rose,(unknown)	70
2	Clinical Characteristics of Patients in a Case Control Study of Sarcoidosisbreakdown → 2001 ·American Journal of Respiratory and Critical Care Medicine ·Robert P. Baughman,Alvin S. Teirstein,Marc A. Judson,(unknown),Henry Yeager,Eddy A. Bresnitz,Louis DePalo,Gary W. Hunninghake,Michael C. Iannuzzi,C Johns,Geoffrey McLennan,David R. Möller,Lee S. Newman,(unknown),Cecile S. Rose,Benjamin A. Rybicki,Steven E. Weinberger,Michael L. Terrin,Genell L. Knatterud,(unknown)	1186
3	Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. 1998 ·PubMed ·Matthew D. Davis,M Fisher,Ronald E. Gangnon,Franca B. Barton,Lloyd M. Aiello,E Y Chew,(unknown),Genell L. Knatterud	343
4	Delayed progression of atherosclerosis in coronary bypass grafts is similar in women compared to men following aggressive cholesterol lowering despite more frequent risk factors: post CABG trial 1998 ·Journal of the American College of Cardiology ·Lucien Campeau,Genell L. Knatterud,Mikołaj Domański,James S. Forrester,Nancy L. Geller,F L Gobel,J. Alan Herd,Byron J. Hoogwerf,D B Hunninghake,Carl W. White,Yves Rosenberg	1
5	Comparison of Preoperative Characteristics of Men and Women Undergoing Coronary Artery Bypass Grafting (The Post Coronary Artery Bypass Graft [CABG] Biobehavioral Study) 1997 ·The American Journal of Cardiology ·Susan M. Czajkowski,Michael L. Terrin,Ruth Lindquist,Byron J. Hoogwerf,Gilles Dupuis,Sally A. Shumaker,(unknown),J. Alan Herd,Diane Treat‐Jacobson,(unknown),Genell L. Knatterud	80
6	Hemorrhagic Events During Therapy With Recombinant Tissue Plasminogen Activator, Heparin, and Aspirin for Unstable Angina (Thrombolysis In Myocardial Ischemia, Phase IIIB Trial) 1997 ·The American Journal of Cardiology ·Edwin G. Bovill,Russell P. Tracy,Genell L. Knatterud,Peter H. Stone,(unknown),Joel M. Gore,Bruce Thompson,Geoffrey H. Tofler,Neal S. Kleiman,Christopher P. Cannon,Eugene Braunwald	24
7	Relation Between Clinical, Angiographic and Ischemic Findings at Baseline and Ischemia-Related Adverse Outcomes at 1 Year in the Asymptomatic Cardiac Ischemia Pilot Study fn1fn1This study was funded by the National Heart, Lung, and Blood Institute, Cardiac Diseases Branch, Division of Heart and Vascular Diseases, National Institutes of Health, Bethesda, Maryland, by Research Contracts HV-90-07, HV90-08, HV-91-05 to HV-91-14. Study medications and placebo were donated by Zeneca Pharmaceuticals Group, Wilmington, Delaware; Marion-Merrell Dow, Kansas City, Missouri; and Pfizer, New York, New York. Support for electrocardiographic data collection was provided in part by Applied Cardiac Systems, Laguna Hills, California; Marquette Electronics, Milwaukee, Wisconsin; Mortara Instrument, Milwaukee, Wisconsin; and Quinton Instruments, Seattle, Washington. Some centers had partial support from grants from the General Clinical Research Center, National Institutes of Health. 1997 ·Journal of the American College of Cardiology ·Carl J. Pepine,(unknown),Thomas Andrews,Sandra Forman,Nancy L. Geller,Genell L. Knatterud,(unknown),Pamela Ouyang,William J. Rogers,George Sopko,Richard M. Steingart,Peter H. Stone,C. Richard Conti	26
8	Asymptomatic cardiac ischemia pilot (ACIP) study: Effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia 1995 ·Journal of the American College of Cardiology ·Martial G. Bourassa,Carl J. Pepine,Sandra Forman,William J. Rogers,Ihor Dyrda,Peter H. Stone,Bernard Chaitman,Barry L. Sharaf,(unknown),Richard F. Davies,Genell L. Knatterud,Michael L. Terrin,George Sopko,C Conti,(unknown)	31
9	1000–39 Advanced Age Does not Diminish the Results of PTCA for Acute Ischemic Syndromes 1995 ·Journal of the American College of Cardiology ·David O. Williams,Bruce Thompson,Eugene Braunwald,Genell L. Knatterud,Barry L. Sharaf,Peter H. Stone	1
10	Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction 1995 ·Neurology ·M. A. Sloan,T R Price,Carol K. Petito,Anna Randall,R. E. Solomon,Michael L. Terrin,(unknown),Désiré Collen,Neal S. Kleiman,Frederick Feit,Joseph D. Babb,Michael V. Herman,William C. Roberts,George Sopko,Edwin G. Bovill,Sandra Forman,Genell L. Knatterud	85
11	Asymptomatic cardiac ischemia pilot (ACIP) study: Impact of anti-ischemia therapy on 12-week rest electrocardiogram and exercise test outcomes 1995 ·Journal of the American College of Cardiology ·Bernard Chaitman,Peter H. Stone,Genell L. Knatterud,Sandra Forman,George Sopko,Martial G. Bourassa,Craig M. Pratt,William J. Rogers,Carl J. Pepine,C. Richard Conti,(unknown)	28
12	Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-Week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study 1994 ·Journal of the American College of Cardiology ·Genell L. Knatterud,Martial G. Bourassa,Carl J. Pepine,Nancy L. Geller,George Sopko,Bernard Chaitman,(unknown),Peter H. Stone,Richard F. Davies,William J. Rogers,John Deanfield,(unknown),Pamela Ouyang,Hiltrud S. Mueller,Barry L. Sharaf,Philip L. Day,Andrew P. Selwyn,C. Richard Conti	85
13	The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: Design of a randomized clinical trial, baseline data and implications for a long-term outcome trial 1994 ·Journal of the American College of Cardiology ·Carl J. Pepine,Nancy L. Geller,Genell L. Knatterud,Martial G. Bourassa,Bernard Chaitman,Richard F. Davies,Philip L. Day,John Deanfield,(unknown),Robert P. McMahon,Hiltrud S. Mueller,Pamela Ouyang,(unknown),Michael A. Proschan,William J. Rogers,Andrew P. Selwyn,Barry L. Sharaf,George Sopko,Peter H. Stone,C. Richard Conti	68
14	Modifiers of timing and possible triggers of acute myocardial infarction in the thrombolysis in myocardial infarction phase II (TIMI II) study group 1992 ·Journal of the American College of Cardiology ·(unknown),James E. Muller,Peter H. Stone,Sandra Forman,Rachel Solomon,Genell L. Knatterud,Eugene Braunwald	142
15	Thrombolysis in Myocardial Infarction (TIMI) phase II trial: Outcome comparison of a “conservative strategy” in community versus tertiary hospitals 1990 ·Journal of the American College of Cardiology ·Frederick Feit,Hiltrud S. Mueller,Eugene Braunwald,(unknown),Morrison Hodges,Michael V. Herman,Genell L. Knatterud	37
16	Intracranial hemorrhage after rt-pa and heparin for acute myocardial infarction — The TIMI II pilot and randomized trial combined experience 1990 ·Journal of the American College of Cardiology ·Joel M. Gore,Michael A. Sloan,(unknown),Michael L. Terrin,Edwin G. Bovill,Désiré Collen,Genell L. Knatterud,Anna Randall,George Sopko	7
17	Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinasebreakdown → 1988 ·Journal of the American College of Cardiology ·Anupama Rao,Craig M. Pratt,Andrew Berke,Allan S. Jaffe,Ira S. Ockene,Theodore Schreiber,William R. Bell,Genell L. Knatterud,Thomas Robertson,Michael L. Terrin	792
18	The thrombolysis in myocardial infarction (TIMI) phase II pilot study: Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty 1987 ·Journal of the American College of Cardiology ·Eugene R. Passamani,Morrison Hodges,Michael V. Herman,Richard Grose,Bernard Chaitman,William J. Rogers,Sandra Forman,Michael L. Terrin,Genell L. Knatterud,Thomas Robertson,Eugene Braunwald	85
19	Persantine-aspirin reinfarction study. Part II. Secondary coronary prevention with persantine and aspirin 1986 ·Journal of the American College of Cardiology ·Christian R. Klimt,Genell L. Knatterud,Jeremiah Stamler,Paul Meier	183
20	The UGDP Controversy: Clinical Trials Versus Clinical Impressions 1972 ·Diabetes ·Thaddeus E. Prout,Genell L. Knatterud,Curtis L. Meinert,Christian R. Klimt	20

About Genell L. Knatterud

Genell L. Knatterud is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Radiology, Nuclear Medicine and Imaging, having authored 106 papers that have together received 10.6k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (34 papers), Coronary Interventions and Diagnostics (26 papers) and Cardiac Imaging and Diagnostics (24 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (5.4k citations), Internal Medicine (838 citations) and Radiology, Nuclear Medicine and Imaging (2.3k citations). Genell L. Knatterud has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Michael L. Terrin, Jeffrey Borer, James E. Dalen, Sandra Forman, Robert Roberts, Lawrence S. Cohen, James H. Chesebro, Charles K. Francis, Harold T. Dodge and Philip A. Ludbrook. Their work appears in journals such as New England Journal of Medicine, JAMA and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact